However, treatment with etanercept, a TNF-α inhibitor, improved arthritis and atherosclerosis without affecting lipid concentrations, suggesting a noncausal relationship between dyslipidemia and atherosclerosis [59]. Here, TNF is linked to atherosclerosis.